Trial: Antibiotics to Treat CCSVI

Home  /  Latest News  /  Current Page

Dr Paul Thibault recently presented the preliminary results of his CCSVI trial at the World Congress of the International Union of Angiology (Sunday 10th August, 2014). After using a Combined Antibiotic Protocol (CAP) to treat chlamydophila pneumoniae (CPn) in people with CCSVI, an average blood flow improvement of 47mls/min was seen . Read the details of the trial here. The study is expected to complete late 2014.